Ebselen protects rat hearts against myocardial ischemia‑reperfusion injury

  • Authors:
    • Bin Cheng
    • Jin‑Peng Zhong
    • Fu‑Xia Wu
    • Guan‑Lan Li
    • Qing‑Xiao Ruan
    • Gang Luo
    • Hong Jiang
  • View Affiliations

  • Published online on: December 12, 2018     https://doi.org/10.3892/etm.2018.7089
  • Pages: 1412-1419
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ebselen is an organoselenium compound that has demonstrated potent antioxidant and anti‑inflammatory effects in previous studies. The present study was conducted to evaluate the effect of ebselen on myocardial ischemia‑reperfusion (I/R) injury in a rat model and to elucidate the related mechanisms. Myocardial infarct size was assessed using triphenyltetrazolium chloride staining. Myocardial injury was evaluated according to the histopathological and ultrastructural alterations of rat hearts and the serum activity levels of cardiac enzymes, including creatine kinase (CK), CK‑MB isoenzyme and lactate dehydrogenase (LDH). Cardiomyocyte apoptosis was detected using the terminal dUTP nick end‑labelling (TUNEL) assay. In addition, the expression of apoptosis‑associated proteins was measured using western blot analysis. In heart tissue specimens the activity of superoxide dismutase (SOD) and glutathione peroxidase (GPx), and levels of malondialdehyde (MDA) and protein carbonyl (PC) were also detected. The results indicated that ebselen reduced I/R‑induced increase in myocardial infarct size and prevented the I/R‑induced decreases in ejection fraction and fractional shortening. Further of note, ebselen improved I/R‑induced rat heart injury. This was indicated by attenuation of histological and ultrastructural changes; reduction of serum CK, CK‑MB and LDH activity levels; and decreased cell apoptosis on TUNEL staining, which was verified by decreased expression of cleaved (C)‑Caspase‑8, C‑Caspase‑3, B‑cell lymphoma 2 (Bcl‑2)‑associated X protein and C‑PARP, and increased expression of Bcl‑2. Additionally, SOD and GPx activity levels were significantly higher, while MDA and PC levels were significantly lower in the ebselen + I/R group compared with in the I/R group. In conclusion, the present results suggested that ebselen serves an important role in protecting against myocardial I/R injury. The underlying mechanism may involve suppression of cardiomyocyte apoptosis and promotion of antioxidant activity.
View Figures
View References

Related Articles

Journal Cover

February-2019
Volume 17 Issue 2

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Cheng B, Zhong JP, Wu FX, Li GL, Ruan QX, Luo G and Jiang H: Ebselen protects rat hearts against myocardial ischemia‑reperfusion injury. Exp Ther Med 17: 1412-1419, 2019
APA
Cheng, B., Zhong, J., Wu, F., Li, G., Ruan, Q., Luo, G., & Jiang, H. (2019). Ebselen protects rat hearts against myocardial ischemia‑reperfusion injury. Experimental and Therapeutic Medicine, 17, 1412-1419. https://doi.org/10.3892/etm.2018.7089
MLA
Cheng, B., Zhong, J., Wu, F., Li, G., Ruan, Q., Luo, G., Jiang, H."Ebselen protects rat hearts against myocardial ischemia‑reperfusion injury". Experimental and Therapeutic Medicine 17.2 (2019): 1412-1419.
Chicago
Cheng, B., Zhong, J., Wu, F., Li, G., Ruan, Q., Luo, G., Jiang, H."Ebselen protects rat hearts against myocardial ischemia‑reperfusion injury". Experimental and Therapeutic Medicine 17, no. 2 (2019): 1412-1419. https://doi.org/10.3892/etm.2018.7089